Treatment with proton pump inhibitors is associated with increased mortality in patients with pyogenic liver abscess

E-ISSN： 1365-2036|47|6|801-808

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.47, Iss.6, 2018-03, pp. : 801-808

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 5, 2015-03 ,pp. : 459-466

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: proton pump inhibitors ‐ severity of liver disease and mortality in patients with cirrhosis

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 704-705

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: proton pump inhibitor treatment and increased mortality in cirrhotic patients

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 11, 2015-06 ,pp. : 1224-1224

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: proton pump inhibitors ‐ severity of liver disease and mortality in patients with cirrhosis – authors' reply

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 706-706

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients

By Mahabaleshwarkar Rohan K. Yang Yi Datar Manasi V. Bentley John P. Strum Matthew W. Banahan Benjamin F. Null Kyle D.

Current Medical Research and Opinion, Vol. 29, Iss. 4, 2013-04 ,pp. : 315-323

Informa Healthcare

Access to resources Recommend Favorite